6320 related articles for article (PubMed ID: 2622597)
1. [The potential for organ-preserving treatment in large uveal melanoma].
Terent'eva LS; Fokin VP
Oftalmol Zh; 1989; (6):338-41. PubMed ID: 2622597
[TBL] [Abstract][Full Text] [Related]
2. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
[TBL] [Abstract][Full Text] [Related]
3. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
[TBL] [Abstract][Full Text] [Related]
4. [A beta ray applicator (106Ru/106Rh) in the treatment of ciliary body melanomas].
Ballin R; Lommatzsch PK; Drost H; Ratajek B
Klin Monbl Augenheilkd; 1985 Aug; 187(2):144-6. PubMed ID: 4057906
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of malignant melanomas of the uvea with 106-ruthenium applicators. Report on the first 100 Essen cases].
Foerster MH; Bornfeld N; Wessing A; Schulz U; Schmitt G; Meyer-Schwickerath G
Klin Monbl Augenheilkd; 1984 Dec; 185(6):490-4. PubMed ID: 6527503
[TBL] [Abstract][Full Text] [Related]
6. [Long-term results of cobalt 60 curietherapy for uveal melanoma].
Bacin F; Kwiatkowski F; Dalens H; Rozan R; Gagyi S; Donnarieix D; Bard JJ; Robert JL
J Fr Ophtalmol; 1998 May; 21(5):333-44. PubMed ID: 9759427
[TBL] [Abstract][Full Text] [Related]
7. Ruthenium plaque radiation therapy for iris and iridociliary melanomas.
Razzaq L; Keunen JE; Schalij-Delfos NE; Creutzberg CL; Ketelaars M; de Keizer RJ
Acta Ophthalmol; 2012 May; 90(3):291-6. PubMed ID: 20670343
[TBL] [Abstract][Full Text] [Related]
8. [Late results in treating uveal melanomas. A comparative evaluation of enucleation and organ-preserving treatment methods].
Libman ES; Brovkina AF; Bezrukov AV
Oftalmol Zh; 1989; (6):336-8. PubMed ID: 2622596
[TBL] [Abstract][Full Text] [Related]
9. Proton beam radiotherapy for uveal melanomas at nice teaching hospital: 16 years' experience.
Caujolle JP; Mammar H; Chamorey E; Pinon F; Herault J; Gastaud P
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):98-103. PubMed ID: 19910136
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of 100 melanomas of the choroid and ciliary body treated by application of ruthenium (RU 106 Rh 106)].
Grange JD; Gerard JP; Ragab M; Quintero P; Delaroche G; Jean-Louis B; Sentenac I; Fontaniere B; Bievelez B
Bull Soc Ophtalmol Fr; 1989 May; 89(5):679-82. PubMed ID: 2590984
[TBL] [Abstract][Full Text] [Related]
11. Possible effects of radiobiological parameters on metastatic spread of uveal melanomas treated with 106Ru plaques.
Kleineidam M; Guthoff R
Ger J Ophthalmol; 1994 Jan; 3(1):22-5; discussion 25-6. PubMed ID: 8142877
[TBL] [Abstract][Full Text] [Related]
12. Techniques and results of 106Ru/106Rh radiation of choroidal tumours.
Busse H; Müller RP
Trans Ophthalmol Soc U K (1962); 1983; 103 ( Pt 1)():72-7. PubMed ID: 6581639
[TBL] [Abstract][Full Text] [Related]
13. The treatment of ciliary body melanoma by beta radiation.
Foerster MH; Wessing A; Meyer-Schwickerath G
Trans Ophthalmol Soc U K (1962); 1983; 103 ( Pt 1)():64-7. PubMed ID: 6581638
[No Abstract] [Full Text] [Related]
14. [Criteria for assessing the efficacy of brachytherapy of uveal melanomas, complications of therapy and there prevention].
Brovkina AF; Zarubeí GD; Val'skií VV
Vestn Oftalmol; 1997; 113(3):14-6. PubMed ID: 9265351
[TBL] [Abstract][Full Text] [Related]
15. [10 years' experience with ruthenium 106/rhodium 106 treatment of malignant melanoma of the choroid--report on 264 irradiated tumors].
Guthoff R; von Domarus D; Steinhorst U; Hallermann D
Klin Monbl Augenheilkd; 1986 Jun; 188(6):576-83. PubMed ID: 3531691
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of Ru-106/Rh-106 brachytherapy for posterior uveal melanoma.
Lommatzsch PK; Werschnik C; Schuster E
Graefes Arch Clin Exp Ophthalmol; 2000 Feb; 238(2):129-37. PubMed ID: 10766281
[TBL] [Abstract][Full Text] [Related]
17. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
[TBL] [Abstract][Full Text] [Related]
18. [Oncologic and functional results of 57 malignant melanoma of the uvea treated by curietherapy].
Bacin F; Albuisson E; Rozan R; Donnarieix D; Verrelle P; Dalens H
J Fr Ophtalmol; 1991; 14(6-7):383-96. PubMed ID: 1779110
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up after uveal melanoma charged particle therapy.
Char DH; Kroll SM; Castro J
Trans Am Ophthalmol Soc; 1997; 95():171-87; discussion 187-91. PubMed ID: 9440169
[TBL] [Abstract][Full Text] [Related]
20. Corneoscleral necrosis after episcleral Au-198 brachytherapy of uveal melanoma.
Chaudhry IA; Liu M; Shamsi FA; Arat YO; Shetlar DJ; Boniuk M
Retina; 2009 Jan; 29(1):73-9. PubMed ID: 18728617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
